Abbott Laboratories stock price

Abbott Laboratories latest news:

  • 10/18/2017 08:00:47

    Abbott shares surge 1.6% after Q3 profit, revenue beats

    Abbott Laboratories shares surged 1.6% in morning trade Wednesday after the company reported third-quarter profit and revenue beats. Earnings for the latest quarter were $603 million, or 32 cents per share, after a loss of $329 million, or a loss of 24 cents per share, in the year-earlier period. Adjusted earnings-per-share were 66 cents, above the FactSet consensus of 65 cents. Revenue rose to $6.83 billion from $5.30 billion, above the FactSet consensus of $6.73 billion. The company also revised its 2017 EPS guidance to between 97 cents and 99 cents, compared with previous guidance of $1.03 to $1.13, and said it expects 2017 adjusted EPS of $2.48 to $2.50, compared with previous guidance of $2.43 to $2.53. The FactSet 2017 EPS consensus is 88 cents and the FactSet 2017 adjusted EPS consensus is $2.49. Abbott expects fourth-quarter EPS of 28 cents to 30 cents, below the FactSet consensus of 31 cents, and adjusted EPS of 72 cents to 74 cents, compared with the FactSet consensus of 73 cents. Abbott shares have surged 14.7% over the last three months, compared with a 4.1% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

  • 09/28/2017 14:46:25

    DexCom and Rite Aid tumble while Abbott and AbbVie rise

    DexCom and Rite Aid fall while Abbott Laboratories and AbbVie jump

  • 09/28/2017 11:49:33

    Abbott wins U.S. antitrust approval to buy Alere with conditions

    WASHINGTON (Reuters) - Abbott Laboratories has won U.S. antitrust approval to buy Alere Inc on condition that it sell certain assets, the Federal Trade Commission said on Thursday.

  • More trends:

    AbbVie Inc.ABBV | Abercrombie & Fitch CompanyANF | Aberdeen Greater China FundGCH | Aberdeen Japan Equity FundJEQ | Aberdeen Singapore FundSGF | ABM Industries IncorporatedABM | Acadia Realty TrustAKR | Accenture plc.ACN | Acco Brands CorporationACCO | Accuride Corporation NewACW |